284 related articles for article (PubMed ID: 16434201)
1. Anticancer activities of novel chalcone and bis-chalcone derivatives.
Modzelewska A; Pettit C; Achanta G; Davidson NE; Huang P; Khan SR
Bioorg Med Chem; 2006 May; 14(10):3491-5. PubMed ID: 16434201
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo.
Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR
Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of chalcone derivatives on steroidal framework and their anticancer activities.
Saxena HO; Faridi U; Kumar JK; Luqman S; Darokar MP; Shanker K; Chanotiya CS; Gupta MM; Negi AS
Steroids; 2007 Nov; 72(13):892-900. PubMed ID: 17850837
[TBL] [Abstract][Full Text] [Related]
4. A boronic-chalcone derivative exhibits potent anticancer activity through inhibition of the proteasome.
Achanta G; Modzelewska A; Feng L; Khan SR; Huang P
Mol Pharmacol; 2006 Jul; 70(1):426-33. PubMed ID: 16636137
[TBL] [Abstract][Full Text] [Related]
5. Anticancer SAR models for MCF-7 and MDA-MB-231 breast cell lines.
Qamar S; Carrasquer CA; Cunningham SL; Cunningham AR
Anticancer Res; 2011 Oct; 31(10):3247-52. PubMed ID: 21965732
[TBL] [Abstract][Full Text] [Related]
6. Novel 5-aminoflavone derivatives as specific antitumor agents in breast cancer.
Akama T; Shida Y; Sugaya T; Ishida H; Gomi K; Kasai M
J Med Chem; 1996 Aug; 39(18):3461-9. PubMed ID: 8784443
[TBL] [Abstract][Full Text] [Related]
7. Antitumor benzothiazoles. 26.(1) 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines.
Mortimer CG; Wells G; Crochard JP; Stone EL; Bradshaw TD; Stevens MF; Westwell AD
J Med Chem; 2006 Jan; 49(1):179-85. PubMed ID: 16392802
[TBL] [Abstract][Full Text] [Related]
8. Anti-breast cancer activity of heteroaryl chalcone derivatives.
Solomon VR; Lee H
Biomed Pharmacother; 2012 Apr; 66(3):213-20. PubMed ID: 22440895
[TBL] [Abstract][Full Text] [Related]
9. Identifying peach and plum polyphenols with chemopreventive potential against estrogen-independent breast cancer cells.
Noratto G; Porter W; Byrne D; Cisneros-Zevallos L
J Agric Food Chem; 2009 Jun; 57(12):5219-26. PubMed ID: 19530711
[TBL] [Abstract][Full Text] [Related]
10. Discovering novel 3-nitroquinolines as a new class of anticancer agents.
Li HH; Huang H; Zhang XH; Luo XM; Lin LP; Jiang HL; Ding J; Chen KX; Liu H
Acta Pharmacol Sin; 2008 Dec; 29(12):1529-38. PubMed ID: 19026174
[TBL] [Abstract][Full Text] [Related]
11. Relationship between anticancer activity and stereochemistry of saldach ligands and their iron(III) complexes.
Hille A; Gust R
Arch Pharm (Weinheim); 2009 Nov; 342(11):625-31. PubMed ID: 19882691
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antitumor activity and QSAR studies of some 4-aminomethylidene derivatives of edaravone.
Marković V; Erić S; Juranić ZD; Stanojković T; Joksović L; Ranković B; Kosanić M; Joksović MD
Bioorg Chem; 2011 Feb; 39(1):18-27. PubMed ID: 21078519
[TBL] [Abstract][Full Text] [Related]
13. Biological evaluation of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone as an anti-breast cancer agent.
Kanaan YM; Das JR; Bakare O; Enwerem NM; Berhe S; Beyene D; Williams V; Zhou Y; Copeland RL
Anticancer Res; 2009 Jan; 29(1):191-9. PubMed ID: 19331150
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anti breast cancer activity of biphenyl based chalcones.
Sharma A; Chakravarti B; Gupt MP; Siddiqui JA; Konwar R; Tripathi RP
Bioorg Med Chem; 2010 Jul; 18(13):4711-20. PubMed ID: 20605470
[TBL] [Abstract][Full Text] [Related]
15. Antimitotic activities of 2-phenylindole-3-carbaldehydes in human breast cancer cells.
Kaufmann D; Pojarová M; Vogel S; Liebl R; Gastpar R; Gross D; Nishino T; Pfaller T; von Angerer E
Bioorg Med Chem; 2007 Aug; 15(15):5122-36. PubMed ID: 17533132
[TBL] [Abstract][Full Text] [Related]
16. A novel series of potent cytotoxic agents targeting G2/M phase of the cell cycle and demonstrating cell killing by apoptosis in human breast cancer cells.
Mandal S; Bérubé G; Asselin E; Mohammad I; Richardson VJ; Gupta A; Pramanik SK; Williams AL; Mandal SK
Bioorg Med Chem Lett; 2007 Sep; 17(17):4955-60. PubMed ID: 17596942
[TBL] [Abstract][Full Text] [Related]
17. Novel highly potent and selective sigma 1 receptor antagonists related to spipethiane.
Piergentili A; Amantini C; Del Bello F; Giannella M; Mattioli L; Palmery M; Perfumi M; Pigini M; Santoni G; Tucci P; Zotti M; Quaglia W
J Med Chem; 2010 Feb; 53(3):1261-9. PubMed ID: 20067271
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of 2,3,4-triarylbenzopyran derivatives as SERM and therapeutic agent for breast cancer.
Kumar S; Deshpande S; Chandra V; Kitchlu S; Dwivedi A; Nayak VL; Konwar R; Prabhakar YS; Sahu DP
Bioorg Med Chem; 2009 Oct; 17(19):6832-40. PubMed ID: 19740667
[TBL] [Abstract][Full Text] [Related]
19. Semisynthesis and in vitro anticancer activities of andrographolide analogues.
Jada SR; Subur GS; Matthews C; Hamzah AS; Lajis NH; Saad MS; Stevens MF; Stanslas J
Phytochemistry; 2007 Mar; 68(6):904-12. PubMed ID: 17234223
[TBL] [Abstract][Full Text] [Related]
20. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.
Vanderlaag K; Su Y; Frankel AE; Grage H; Smith R; Khan S; Safe S
Breast Cancer Res Treat; 2008 May; 109(2):273-83. PubMed ID: 17624585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
